BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 19617993)

  • 1. An ethylene-glycol decorated ruthenium(ii) complex for two-photon photodynamic therapy.
    Boca SC; Four M; Bonne A; van der Sanden B; Astilean S; Baldeck PL; Lemercier G
    Chem Commun (Camb); 2009 Aug; (30):4590-2. PubMed ID: 19617993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An amphiphilic ruthenium(II)-polypyridyl appended porphyrin as potential bifunctional two-photon tumor-imaging and photodynamic therapeutic agent.
    Poon CT; Chan PS; Man C; Jiang FL; Wong RN; Mak NK; Kwong DW; Tsao SW; Wong WK
    J Inorg Biochem; 2010 Jan; 104(1):62-70. PubMed ID: 19880187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ruthenium porphyrin compounds for photodynamic therapy of cancer.
    Schmitt F; Govindaswamy P; Süss-Fink G; Ang WH; Dyson PJ; Juillerat-Jeanneret L; Therrien B
    J Med Chem; 2008 Mar; 51(6):1811-6. PubMed ID: 18298056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodecarbonylation of ruthenium carbonyl octaethylporphyrin via stepwise two-photon absorption of visible light.
    Ishii K; Hoshino S; Kobayashi N
    Inorg Chem; 2004 Dec; 43(25):7969-71. PubMed ID: 15578833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microwave synthesis of a rare [Ru(2)L(3)](4+) triple helicate and its interaction with DNA.
    Glasson CR; Meehan GV; Clegg JK; Lindoy LF; Smith JA; Keene FR; Motti C
    Chemistry; 2008; 14(34):10535-8. PubMed ID: 18972465
    [No Abstract]   [Full Text] [Related]  

  • 6. A novel strategy for targeting photodynamic therapy. Molecular combo of photodynamic agent zinc(II) phthalocyanine and small molecule target-based anticancer drug erlotinib.
    Zhang FL; Huang Q; Zheng K; Li J; Liu JY; Xue JP
    Chem Commun (Camb); 2013 Oct; 49(83):9570-2. PubMed ID: 24018863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-photon absorption of metal-organic DNA-probes.
    Hanczyc P; Norden B; Samoc M
    Dalton Trans; 2012 Mar; 41(11):3123-5. PubMed ID: 22293935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An estrogen receptor targeted ruthenium complex as a two-photon photodynamic therapy agent for breast cancer cells.
    Zhao X; Li M; Sun W; Fan J; Du J; Peng X
    Chem Commun (Camb); 2018 Jun; 54(51):7038-7041. PubMed ID: 29873358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ruthenium(II) complexes for two-photon absorption-based optical power limiting.
    Girardot C; Cao B; Mulatier JC; Baldeck PL; Chauvin J; Riehl D; Delaire JA; Andraud C; Lemercier G
    Chemphyschem; 2008 Aug; 9(11):1531-5. PubMed ID: 18618573
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of the Medicinal Potential of Two Ruthenium(II) Polypyridine Complexes as One- and Two-Photon Photodynamic Therapy Photosensitizers.
    Hess J; Huang H; Kaiser A; Pierroz V; Blacque O; Chao H; Gasser G
    Chemistry; 2017 Jul; 23(41):9888-9896. PubMed ID: 28509422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ru(II) complexes of new tridentate ligands: unexpected high yield of sensitized 1O2.
    Liu Y; Hammitt R; Lutterman DA; Joyce LE; Thummel RP; Turro C
    Inorg Chem; 2009 Jan; 48(1):375-85. PubMed ID: 19035764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of photobleaching in photodynamic therapy using the photodecarbonylation reaction of ruthenium phthalocyanine complexes via stepwise two-photon excitation.
    Ishii K; Shiine M; Shimizu Y; Hoshino S; Abe H; Sogawa K; Kobayashi N
    J Phys Chem B; 2008 Mar; 112(10):3138-43. PubMed ID: 18284227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and cellular studies of nonaggregated water-soluble phthalocyanines.
    Liu W; Jensen TJ; Fronczek FR; Hammer RP; Smith KM; Vicente MG
    J Med Chem; 2005 Feb; 48(4):1033-41. PubMed ID: 15715471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Water-soluble green perylenediimide (PDI) dyes as potential sensitizers for photodynamic therapy.
    Yukruk F; Dogan AL; Canpinar H; Guc D; Akkaya EU
    Org Lett; 2005 Jul; 7(14):2885-7. PubMed ID: 15987161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear targets of photodynamic tridentate ruthenium complexes.
    Zhao R; Hammitt R; Thummel RP; Liu Y; Turro C; Snapka RM
    Dalton Trans; 2009 Dec; (48):10926-31. PubMed ID: 20023923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A GSH-activatable ruthenium(ii)-azo photosensitizer for two-photon photodynamic therapy.
    Zeng L; Kuang S; Li G; Jin C; Ji L; Chao H
    Chem Commun (Camb); 2017 Feb; 53(12):1977-1980. PubMed ID: 28119967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stabilization of ruthenium sensitizers to TiO2 surfaces through cooperative anchoring groups.
    Brown DG; Schauer PA; Borau-Garcia J; Fancy BR; Berlinguette CP
    J Am Chem Soc; 2013 Feb; 135(5):1692-5. PubMed ID: 23343106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of methyl substitution on radiative and solvent quenching rate constants of [Ru(phen)2dppz]2+ in polyol solvents and bound to DNA.
    Olofsson J; Wilhelmsson LM; Lincoln P
    J Am Chem Soc; 2004 Dec; 126(47):15458-65. PubMed ID: 15563173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A quenched binuclear ruthenium(II) dimer activated by another photosensitizer.
    Lou K; Lovell JF
    Chem Commun (Camb); 2014 Mar; 50(24):3231-3. PubMed ID: 24522513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dyad as photocatalyst for light-driven sulfide oxygenation with water as the unique oxygen atom source.
    Hamelin O; Guillo P; Loiseau F; Boissonnet MF; Ménage S
    Inorg Chem; 2011 Sep; 50(17):7952-4. PubMed ID: 21793512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.